Prothena Future Growth
Future criteria checks 2/6
Prothena is forecast to grow earnings and revenue by 38.5% and 41.1% per annum respectively while EPS is expected to grow by 39.1% per annum.
Key information
38.5%
Earnings growth rate
39.1%
EPS growth rate
| Biotechs earnings growth | 37.3% |
| Revenue growth rate | 41.1% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 192 | -156 | -87 | N/A | 4 |
| 12/31/2025 | 78 | -229 | -133 | N/A | 8 |
| 12/31/2024 | 141 | -120 | -109 | N/A | 8 |
| 9/30/2024 | 133 | -132 | -155 | -153 | N/A |
| 6/30/2024 | 217 | -51 | -101 | -99 | N/A |
| 3/31/2024 | 89 | -172 | -162 | -159 | N/A |
| 12/31/2023 | 91 | -147 | -137 | -134 | N/A |
| 9/30/2023 | 141 | -73 | -89 | -88 | N/A |
| 6/30/2023 | 58 | -141 | -130 | -129 | N/A |
| 3/31/2023 | 55 | -128 | -119 | -119 | N/A |
| 12/31/2022 | 54 | -117 | -109 | -109 | N/A |
| 9/30/2022 | 5 | -156 | -127 | -126 | N/A |
| 6/30/2022 | 143 | -1 | 16 | 17 | N/A |
| 3/31/2022 | 202 | 67 | 88 | 89 | N/A |
| 12/31/2021 | 201 | 67 | 92 | 93 | N/A |
| 9/30/2021 | 200 | 69 | 96 | 96 | N/A |
| 6/30/2021 | 61 | -70 | -36 | -36 | N/A |
| 3/31/2021 | 1 | -124 | -91 | -91 | N/A |
| 12/31/2020 | 1 | -111 | -81 | -80 | N/A |
| 9/30/2020 | 1 | -102 | -76 | -76 | N/A |
| 6/30/2020 | 1 | -91 | -66 | -65 | N/A |
| 3/31/2020 | 1 | -80 | -59 | -59 | N/A |
| 12/31/2019 | 1 | -78 | -54 | -53 | N/A |
| 9/30/2019 | 1 | -79 | -62 | -60 | N/A |
| 6/30/2019 | 1 | -84 | -86 | -84 | N/A |
| 3/31/2019 | 1 | -128 | -16 | -14 | N/A |
| 12/31/2018 | 1 | -156 | -30 | -28 | N/A |
| 9/30/2018 | 1 | -181 | -47 | -47 | N/A |
| 6/30/2018 | 1 | -209 | N/A | -31 | N/A |
| 3/31/2018 | 27 | -167 | N/A | -125 | N/A |
| 12/31/2017 | 28 | -153 | N/A | -131 | N/A |
| 9/30/2017 | 27 | -154 | N/A | -125 | N/A |
| 6/30/2017 | 28 | -145 | N/A | -138 | N/A |
| 3/31/2017 | 1 | -168 | N/A | -129 | N/A |
| 12/31/2016 | 1 | -160 | N/A | -116 | N/A |
| 9/30/2016 | 1 | -135 | N/A | -102 | N/A |
| 6/30/2016 | 1 | -115 | N/A | -89 | N/A |
| 3/31/2016 | 1 | -93 | N/A | -73 | N/A |
| 12/31/2015 | 2 | -81 | N/A | -59 | N/A |
| 9/30/2015 | 3 | -70 | N/A | -55 | N/A |
| 6/30/2015 | 4 | -60 | N/A | -51 | N/A |
| 3/31/2015 | 19 | -40 | N/A | -33 | N/A |
| 12/31/2014 | 51 | -7 | N/A | -1 | N/A |
| 9/30/2014 | 49 | -5 | N/A | 2 | N/A |
| 6/30/2014 | 48 | -2 | N/A | 4 | N/A |
| 3/31/2014 | 33 | -14 | N/A | -9 | N/A |
| 12/31/2013 | 1 | -41 | N/A | -32 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0Y3M is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0Y3M is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0Y3M is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0Y3M's revenue (41.1% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0Y3M's revenue (41.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0Y3M's Return on Equity is forecast to be high in 3 years time